CIK 0001576280 · Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454139254
- Phone
- 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,739,100
- in 9 filings, $213K under 10b5-1 plans
Net −$9,739,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Monroe Terilyn J. Chief People Officer | Option exercise | +1,361 | 25,078 | ||
| 2026-07-01 | Monroe Terilyn J. Chief People Officer | Shares withheld for taxes | −2,099 | $170.77 | $358K | 22,979 |
| 2026-07-01 | Monroe Terilyn J. Chief People Officer | Option exercise · Restricted Stock Units | −2,659 | 13,296 | ||
| 2026-07-01 | Monroe Terilyn J. Chief People Officer | Option exercise · Restricted Stock Units | −1,361 | 9,522 | ||
| 2026-06-30 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise | +2,817 | 1,884,153 | ||
| 2026-06-30 | Talasaz AmirAli Co-Chief Executive Officer | Shares withheld for taxes | −1,428 | $150.03 | $214K | 1,882,725 |
| 2026-06-30 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −2,817 | 5,634 | ||
| 2026-06-30 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise | +2,817 | 2,015,736 | ||
| 2026-06-30 | Eltoukhy Helmy Co-Chief Executive Officer | Shares withheld for taxes | −1,428 | $150.03 | $214K | 2,014,308 |
| 2026-06-30 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −2,817 | 5,634 | ||
| 2026-06-30 | Krognes Steve E. Director | Option exercise | +155 | 14,580 | ||
| 2026-06-30 | Krognes Steve E. Director | Option exercise · Restricted Stock Units | −155 | 0 | ||
| 2026-06-29 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise 10b5-1 | +143,028 | $4.18 | $598K | 2,024,364 |
| 2026-06-29 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −25,812 | $150.53 | $3.9M | 1,998,552 |
| 2026-06-29 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −70,513 | $151.47 | $10.7M | 1,928,039 |
| 2026-06-29 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −46,663 | $152.20 | $7.1M | 1,881,376 |
| 2026-06-29 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −40 | $153.00 | $6K | 1,881,336 |
| 2026-06-29 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −143,028 | 28,997 | ||
| 2026-06-26 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise 10b5-1 | +111,804 | $4.18 | $467K | 1,998,308 |
| 2026-06-26 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −64,037 | $150.49 | $9.6M | 1,934,271 |
Page 11 of 22 · 421 trades